LXRX - Lexicon Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LXRX is currently covered by 1 analysts with an average price target of $2.91. This is a potential upside of $2.21 (315.71%) from yesterday's end of day stock price of $0.7.

Lexicon Pharmaceuticals's activity chart (see below) currently has 38 price targets and 35 ratings on display. The stock rating distribution of LXRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.14% with an average time for these price targets to be met of 74 days.

Highest price target for LXRX is $3, Lowest price target is $1, average price target is $4.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 12-Dec-2023. First documented stock forecast 11-Oct-2013.

Currently out of the existing stock ratings of LXRX, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$4

$2.73 (214.96%)

$8

1 years 6 months ago
(12-Dec-2023)

4/15 (26.67%)

$2.82 (238.98%)

47

Buy

$10

$8.73 (687.40%)

$10

2 years 8 months 9 days ago
(03-Oct-2022)

0/2 (0%)

$7.55 (308.16%)

Hold

$7

$5.91 (542.20%)

4 years 4 months 14 days ago
(29-Jan-2021)

3/3 (100%)

$1.33 (13.05%)

55

Buy

$2

$0.73 (57.48%)

4 years 4 months 14 days ago
(29-Jan-2021)

2/6 (33.33%)

$-5.91 (-74.72%)

409

Hold

4 years 4 months 28 days ago
(15-Jan-2021)

1/1 (100%)

$0.8 (36.36%)

7

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LXRX (Lexicon Pharmaceuticals) average time for price targets to be met?

On average it took 74 days on average for the stock forecasts to be realized with a an average price target met ratio 37.14

Which analyst has the current highest performing score on LXRX (Lexicon Pharmaceuticals) with a proven track record?

JESSICA FYE

Which analyst has the current lower performing score on LXRX (Lexicon Pharmaceuticals) with a proven track record?

YASMEEN RAHIMI

Which analyst has the most public recommendations on LXRX (Lexicon Pharmaceuticals)?

Jessica Fye works at JPMORGAN and has 18 price targets and 11 ratings on LXRX

Which analyst is the currently most bullish on LXRX (Lexicon Pharmaceuticals)?

Yasmeen Rahimi with highest potential upside - $8.73

Which analyst is the currently most reserved on LXRX (Lexicon Pharmaceuticals)?

Stephen Willey with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?